MCP-1 levels in serum have been shown to be associated with cognitive decline and decreased memory in older adults, particularly those with Aβ amyloidosis, and to be increased in early-stage Alzheimer’s disease [45–47]. The gene discussed is CCL2; the disease is early-onset autosomal dominant Alzheimer disease.